Diabetes & Metabolic Devices
Manufacturers of continuous glucose monitors, insulin pumps, and metabolic disease management devices.
- 5
- Verticals
Overview
Diabetes & Metabolic Devices covers manufacturers of continuous glucose monitors (CGMs), insulin pumps, and metabolic-disease management devices. It is one of the fastest-growing medtech categories, driven by the explosive adoption of CGMs (Dexcom, Abbott Libre) and automated insulin delivery (Insulet, Tandem, Medtronic).
CGM expansion beyond type 1 into type 2 and even non-diabetic wellness, plus the interplay with GLP-1 obesity drugs, are reshaping the category's growth. It is innovation- and consumable-driven, with recurring sensor and supply revenue, and is a high-growth focus for both strategics and investors.
Market snapshot
Within electromedical and instrument manufacturing (NAICS 334510/339112); the Census Bureau does not split out diabetes devices, so the segment is not separately sized.
Business model & economics
- Revenue model
- Devices plus high-margin recurring sensors and supplies
- Recurring revenue
- High — recurring CGM sensors and pump supplies
- EBITDA margin
- Strong — recurring-consumable economics
- Capex intensity
- High
- Among the fastest-growing medtech categories.
- CGM adoption expanding into type 2 and wellness.
- Recurring sensor-and-supply razor-and-blade model.
M&A deal context
Who’s acquiring
What’s driving deals
- CGM and automated-insulin-delivery growth.
- Expansion into type 2 and metabolic wellness.
- Recurring-consumable economics.
Verticals in this segment
- 4.8.3.1Blood Glucose Monitoring Devices
Traditional blood glucose meters and test strips.
- 4.8.3.2Continuous Glucose Monitors (CGM)
Wearable devices continuously measuring blood glucose levels.
- 4.8.3.3Diabetes Management Technology
Connected devices and apps managing diabetes care.
- 4.8.3.4Insulin Pump Systems
Wearable insulin delivery and automated insulin delivery systems.
- 4.8.3.5Metabolic Surgery Devices
Bariatric surgery tools and metabolic procedure implants.
Find Diabetes & Metabolic Devices acquisition targets
Search Acquisera’s index for companies classified under Diabetes & Metabolic Devices (4.8.3) and build a targeted deal pipeline.
Search companies